Finding new ways to diagnose childhood brain tumours

March 24, 2023

John said: “Until the age of nineteen months Sophie seemed to be a normally developing little girl, she walked at eleven months and her speech was well ahead of her age. She was transferred to Addenbrooke’s Hospital, Cambridge, for further tests and a medulloblastoma tumour was confirmed. John said: “None of us had any knowledge of brain tumours and it became a huge learning curve. After her death, Sophie’s family set up The Sophie Elin Harper Fund with The Brain Tumour Charity to raise funds and awareness of brain tumours. John said: “The side effects Sophie had following surgery, with the insult to her brain, were huge and totally life changing.

John Huggins’ granddaughter Sophie Harper was diagnosed with medulloblastoma in 2006. 

John said: “Until the age of nineteen months Sophie seemed to be a normally developing little girl, she walked at eleven months and her speech was well ahead of her age. From nineteen months she started to vomit regularly and when her mother took her to the doctors on day four, he diagnosed a virus. After ten days my daughter returned to the doctor, but again he said it was a virus. Sophie was taken to the doctor a number of times over the next two and a half months and there was no change with the doctor’s diagnosis. Sophie then started to lose her ability to walk, no longer was she the happy child she was, complaining of head pain, started falling over regularly and wanting to be carried around. It was only then the doctor agreed for Sophie to have a scan.”

Sophie’s scan took place at Norwich University Hospital and revealed a mass on her cerebellum.  She was transferred to Addenbrooke’s Hospital, Cambridge, for further tests and a medulloblastoma tumour was confirmed. 

John said:  “None of us had any knowledge of brain tumours and it became a huge learning curve.  At that point Mum and Dad had to decide whether to take the option of curative or palliative care. Sophie always had a big personality and was such a fighter with any illness, so Mum and Dad decided they had to give her the tools to fight with and take the curative option”.

The following week, Sophie underwent an operation to try and remove the tumour and the family waited anxiously in the garden of Addenbrooke’s Hospital for news. The operation was expected to last around three to four hours but Sophie was in surgery for seven and a half. 

John said: “Sophie didn’t regain consciousness for thirty two days, due to the insult to her brain. She spent three months in intensive care and was now needing an oxygen supplement and having to be fed through a gastrostomy tube. Both of these would stay for the next six years of her life.

“It also became clear that there were other side effects from the operation: her speech was significantly impacted and she was unable to hold our gaze and her movements were uncoordinated and clumsy. During the time of her treatment she received more than a hundred transfusions of blood products due to low blood cell counts, but none of us can remember a single day, when she didn’t make us laugh or brighten our day. She had an amazing ability to do that. 

“It is true to say, surgery had a dramatic effect on Sophie, she was no longer the child we knew before the operation.”

Just before Sophie’s eighth birthday, her family were devastated when a scan revealed another growth on her brain.  She was given three months to live, but survived almost a year and sadly died shortly before her ninth birthday in 2013.

After her death, Sophie’s family set up The Sophie Elin Harper Fund with The Brain Tumour Charity to raise funds and awareness of brain tumours. Their fundraising to date totals a remarkable £38,000. 

John said: “The side effects Sophie had following surgery, with the insult to her brain, were huge and totally life changing.

“Sophie lived a very cruel life, in and out of hospital. Even the shunt fitted in her brain had to be replaced on three occasions. She never regained the ability to walk, and was always fed through a gastrostomy tube, together with an oxygen supplement, but she never complained.

“The possibility of avoiding side effects and unnecessary surgery would be a real turning point in the treatment of medulloblastoma.”

The source of this news is from University of Cambridge

Popular in Research

1

Apr 6, 2024

New Jersey earthquake makes waves in Baltimore

2

Apr 16, 2024

From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic

3

Apr 5, 2024

UBC Board of Governors approves balanced operating budget for 2024/25

4

Apr 9, 2024

Propelling atomically layered magnets toward green computers

5

5 days ago

Ehab Abouheif named Fellow of the American Association for the Advancement of Science

Roundup of Key Statements

Oct 14, 2023

New path facilitates campus access for students

Feb 2, 2023